We are live on !
Find out more
PM
Parametrica Management Portfolio holdings
AUM
$142M
Turnover
60%
1-Year Est. Return
113.92%
This Fund
S&P 500
This Quarter Est. Return
+13%
1 Year Est. Return
+113.92%
3 Year Est. Return
+543.23%
5 Year Est. Return
+714.65%
10 Year Est. Return
–
AUM
$135M
AUM Growth
-$72.6M
(-35%)
Cap. Flow
-$83.8M
Cap. Flow % of AUM
Cap. Flow %
-61.9%
Top 10 Holdings %
Top 10 Hldgs %
44.33%
Holding
205
New
45
Increased
16
Reduced
31
Closed
110
Avg Time Held
0.3
years
Top 10 Avg Time Held
0.3
years
Top 20 Avg Time Held
0.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioNTech
BNTX
|
+$3.07M |
| 2 |
StoneCo
STNE
|
+$2.15M |
| 3 |
Tilray
TLRY
|
+$2.07M |
| 4 |
Salesforce
CRM
|
+$2.02M |
| 5 |
Iovance Biotherapeutics
IOVA
|
+$1.93M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JD.com
JD
|
+$8.2M |
| 2 |
Norwegian Cruise Line
NCLH
|
+$7.85M |
| 3 |
Tencent Music
TME
|
+$7.63M |
| 4 |
Nexstar Media Group
NXST
|
+$5.3M |
| 5 |
CureVac
CVAC
|
+$3.97M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 28.24% |
| 2 | Consumer Discretionary | 21.22% |
| 3 | Healthcare | 18.41% |
| 4 | Technology | 17.13% |
| 5 | Industrials | 5.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Meta Platforms (Facebook)
META
$1.63T
| $14.4M | 10.6% |
41,293
-280
| -0.7% | -$89.8K |
2020 Q1
5 quarters
|
|
2
DELISTED
Amicus Therapeutics
FOLD
| $6.69M | 4.94% |
694,196
+86,168
| +14% | +$841K |
2021 Q1
1 quarter
|
|
3
Amazon
AMZN
$2.63T
| $6.08M | 4.49% |
35,360
-10,600
| -23% | -$1.76M |
2020 Q1
5 quarters
|
|
|
4
BioNTech
BNTX
$22.4B
| $5.58M | 4.12% |
24,897
+16,305
| +190% | +$3.07M |
2020 Q4
2 quarters
|
|
|
5
Norwegian Cruise Line
NCLH
$8.37B
| $5.45M | 4.03% |
185,473
-260,630
| -58% | -$7.85M |
2020 Q3
3 quarters
|
|
6
Sea Limited
SE
$46.9B
| $4.89M | 3.61% |
17,810
| – | – |
2021 Q1
1 quarter
|
|
7
Synchrony
SYF
$25B
| $4.8M | 3.54% |
98,865
+3,449
| +4% | +$157K |
2020 Q2
4 quarters
|
|
8
Alphabet (Google) Class A
GOOGL
$3.49T
| $4.59M | 3.39% |
37,580
-60
| -0.2% | -$7.01K |
2021 Q1
1 quarter
|
|
9
United Airlines
UAL
$34.2B
| $3.96M | 2.92% |
75,651
-45
| -0.1% | -$2.5K |
2020 Q2
4 quarters
|
|
10
Micron Technology
MU
$1.06T
| $3.65M | 2.69% |
42,942
+17,193
| +67% | +$1.45M |
2020 Q4
2 quarters
|
|
11
Vale
VALE
$47.6B
| $3.3M | 2.44% |
144,630
| – | – |
2021 Q1
1 quarter
|
|
|
12
StoneCo
STNE
$1.84B
| $3.13M | 2.31% |
46,587
+33,135
| +246% | +$2.15M |
2020 Q4
2 quarters
|
|
13
NVIDIA
NVDA
$5.16T
| $3.11M | 2.3% |
155,400
-66,520
| -30% | -$1.07M |
2020 Q3
3 quarters
|
|
14
Alphabet (Google) Class C
GOOG
$3.47T
| $2.85M | 2.11% |
22,760
+120
| +0.5% | +$14.3K |
2020 Q4
2 quarters
|
|
|
TWTR
15
DELISTED
Twitter, Inc.
TWTR
| $2.68M | 1.98% |
38,952
+28,426
| +270% | +$1.74M |
2021 Q1
1 quarter
|
|
16
Baidu
BIDU
$26.8B
| $2.6M | 1.92% |
12,780
-2,709
| -17% | -$542K |
2020 Q4
2 quarters
|
|
17
ASML
ASML
$646B
| $2.42M | 1.78% |
3,498
-900
| -20% | -$594K |
2021 Q1
1 quarter
|
|
18
Cinemark Holdings
CNK
$4.64B
| $2.31M | 1.71% |
105,142
-153,044
| -59% | -$3.39M |
2020 Q4
2 quarters
|
|
19
Novavax
NVAX
$1.73B
| $2.17M | 1.6% |
10,200
+8,917
| +695% | +$1.63M |
2021 Q1
1 quarter
|
|
|
20
Salesforce
CRM
$190B
| $2.14M | 1.58% |
+8,748
| New | +$2.02M |
2021 Q2
0 quarters
|
|
|
21
Tilray
TLRY
$390M
| $2.13M | 1.58% |
+11,809
| New | +$2.07M |
2021 Q2
0 quarters
|
|
22
Niu Technologies
NIU
$147M
| $2.12M | 1.57% |
64,964
-52,782
| -45% | -$1.76M |
2020 Q4
2 quarters
|
|
23
Bilibili
BILI
$5.32B
| $2.1M | 1.55% |
17,249
-36,100
| -68% | -$3.91M |
2020 Q4
2 quarters
|
|
24
Carnival Corporation Ltd
CCL
$38.8B
| $2.09M | 1.54% |
79,386
-121,147
| -60% | -$3.39M |
2020 Q4
2 quarters
|
|
|
25
Iovance Biotherapeutics
IOVA
$4.33B
| $1.93M | 1.43% |
+74,275
| New | +$1.93M |
2021 Q2
0 quarters
|
|
Similar funds
KC
Parametrica Management's Q2 2021 Portfolio in Review
As of Q2 2021, Parametrica Management held 205 positions worth $135M, down 35% from $208M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Parametrica Management withdrew a net $83.8M in Q2 2021, closing 110 positions and reducing 31 holdings. Its most notable exit was CureVac, an estimated $3.97M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 28% of assets, up from 27% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Parametrica Management opened a new position in Tilray worth $2.13M.
- Parametrica Management's largest Q2 2021 buy was Tilray: 11,809 shares worth $2.13M.
- Parametrica Management added most to BioNTech in Q2 2021, an estimated $3.07M increase.
- Parametrica Management's biggest Q2 2021 reduction was JD.com, cutting an estimated $8.2M.
- Parametrica Management fully exited CureVac in Q2 2021, selling an estimated $3.97M.
- Parametrica Management's ten largest holdings make up 44% of its $135M portfolio in Q2 2021.
- Parametrica Management opened 45 new positions and closed 110 in Q2 2021.
- Parametrica Management's portfolio value fell 35% quarter-over-quarter to $135M.
Based on Parametrica Management's 13F filing for Q2 2021, filed 13 Aug 2021.